A randomized controlled trial adding fluvastatin to peginterferon and ribavirin for naïve genotype 1 hepatitis C patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A randomized controlled trial adding fluvastatin to peginterferon and ribavirin for naïve genotype 1 hepatitis C patients

Published:2013-03-06 Issue:9 Volume:20 Page:622-627
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:J Viral Hepat

Author:

Bader T.¹²,Hughes L. D.¹,Fazili J.¹²,Frost B.¹,Dunnam M.³,Gonterman A.¹,Madhoun M.¹²,Aston C. E.⁴

Affiliation:

1. VA Medical Center; Oklahoma City OK USA

2. Department of Medicine; University of Oklahoma Health Sciences Center; Oklahoma City OK USA

3. VA Medical Center; San Antonio TX USA

4. Department of Pediatrics; University of Oklahoma Health Sciences Center; Oklahoma City OK USA

Funder

VA Research Foundation of Oklahoma City

Oklahoma Center for Advancement of Science and Technology

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jvh.12085/fullpdf

Reference19 articles.

1. Disruption of hepatitis C virus RNA replication through inhibition of host protein geranylgeranylation;Ye;Proc Natl Acad Sci U S A,2003

2. Different anti-HCV profiles of statins and their potential for combination therapy with interferon;Ikeda;Hepatology,2006

3. Fluvastatin inhibits hepatitis C replication in humans;Bader;Am J Gastroenterol,2008

4. Antiviral action of ribavirin in chronic hepatitis C;Pawlotsky;Gastroenterology,2004

5. Rosuvastatin compared to fluvastatin, simvastatin, and ribavirin for anti-HCV activity in vitro;Bader;J Hepatol,2010

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Statins in Chronic Liver Disease: Review of the Literature and Future Role;Seminars in Liver Disease;2024-05

2. Hepatitis C Virus (HCV)-Ribonucleic Acid (RNA) As a Biomarker for Lymphoid Malignancy with HCV Infection;Cancers;2023-05-21

3. Interdependent Impact of Lipoprotein Receptors and Lipid-Lowering Drugs on HCV Infectivity;Cells;2021-06-29

4. ACG Clinical Guideline: Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury;American Journal of Gastroenterology;2021-05

5. Pharmacophore-based approaches in the rational repurposing technique for FDA approved drugs targeting SARS-CoV-2 Mpro;RSC Advances;2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3